Indications for the Use of Atypical Antipsychotics in the Elderly

Allen, R. L., Walker, Z., D'Ath, P. J., and Katona, C. L. E. (1995). Risperidone for psychotic and behavioural symptoms in Lewy body dementia. Lancet 346: 185.

Altamura, A. C., and Curreli, R. (1998). Antipsychotics in the elderly: The use of “typical” vs. “atypical” compounds. In Brunello, N., Langer, S. Z., and Racagni, G. (eds.), Mental Disorders in the Elderly: New Therapeutic Approaches. International Academy of Biomedical Drug Research, Karger, Basel, Vol. 13, pp. 125–138.

Arevalo, G. J. G., and Gershanik, O. S. (1993). Modulatory effect of clozapine on levodopa response in Parkinsons-Disease—a preliminary study. Mov. Disord. 8: 349–354.

Ball, C. J. (1992). The use of clozapine in older people. Int. J. Geriatr. Psychiatry 7: 689–692.

Bashir, K., and Manyam, B. V. (1994). Clozapine for the control of hemiballismus. Clin. Neuropharmacol. 17: 477–480.

Bennett, J. P., Landow, E. R., Dietrich, S., and Schuh, L. A. (1994). Suppression of dyskinesias in advanced Parkinsons-Disease—moderate daily clozapine doses provide long-term dyskinesia reduction. Mov. Disord. 9: 409–414.

Bennett, J. P., Landow, E. R., and Schuh, L. A. (1993). Suppression of dyskinesias in advanced Parkinsons-Disease. 2. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms. Neurology 43: 1551–1555.

Berman, I., Merson, A., Rachov-Pavlov, J., Allan, E., Davidson, M., and Losonczy, M. F. (1996). Risperidone in elderly schizophrenic patients. Am. J. Geriatr. Psychiatry 4: 173–179.

Bernardi, F., and Del Zompo, M. (1990). Clozapine in idiopathic Parkinson's disease. Neurology 40: 1151–1152.

Bezchlibnyk-Butler, K. Z., and Jeffries, J. J. (eds.). (2000). Clinical Handbook of Psychotropic Drugs, 10th Rev. edn., Hogrefe & Huber, Seattle.

Bonuccelli, U., Ceravolo, R., Maremmani, C., Nuti, A., Rossi, G., and Muratorio, A. (1994). Clozapine in Huntingtons-Chorea. Neurology 44: 821–823.

Buckley, P. F. (1999). The role of typical and atypical antipsychotic medications in the management of agitation and aggression. J. Clin. Psychiatry 60(suppl. 10): 52–60.

Caine, E. D., Polinsky, R. J., Kartzinel, R., and Ebert, M. H. (1979). The trial use of clozapine for abnormal involuntary movement disorders. Am. J. Psychiatry 136: 317–320.

Campbell, M., Young, P. I., Batemen, D. N., Smith, J. M., and Thomas, S. H. L. (1999). The use of atypical antipsychotics in the management of schizophrenia. Br. J. Clin. Pharmacol. 47: 13–22.

Cantillon, M., De La Puente, A. M., and Palmer, B. W. (1998). Psychosis in Alzheimer's disease. Semin. Clin. Neuropsychiatry 3: 34–40.

Carpenter, W. T., Arango, C., Buchanan, R. W., and Kirkpatrick, B. (1999). Deficit psychopathology and a paradigm shift in schizophrenia research. Biol. Psychiatry 46: 352–360.

Catterson, M. L., Preskorn, S. H., and Martin, R. L. (1997). Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr. Clin. N. Am. 20: 205–218.

Ceravolo, R., Salvetti, S., Dell'Agnello G., D'Avino, C., and Bonuccelli, U. (1996). Pharmacological tools in the study of essential tremor. Mov. Disord. 11(suppl. 1): 255.

Chacko, R. C., Hurley, R. A., Harper, R. G., Jankovic, J., and Cardoso, F. (1995). Clozapine for acute and maintenance treatment of psychosis in Parkinsons-Disease. J. Neuropsychiatry Clin. Neurosc. 7: 471–475.

Chacko, R. C., Hurley, R. A., and Jankovic, J. (1993). Clozapine use in diffuse Lewy body disease. J. Neuropsychiatry Clin. Neurosc. 5: 206–208.

Chan, Y. C., Pariser, S. F., and Neufeld, G. (1999). Atypical antipsychotics in older adults. Pharmacotherapy 10: 811–822.

Chengappa, K. N. R., Baker, R. W., Kreinbrook, S. B., and Adair, D. (1995). Clozapine use in female geriatric patients with psychoses. J. Geriatr. Psychiatry Neurol. 8: 12–15.

Cohen, C. I. (1990). Outcome of schizophrenia into later life: An overview. Gerontologist 30: 790–797.

Colosimo, C., Cassetta, E., Bentivoglio, A. R., and Albanese, A. (1995). Clozapine in Huntington's disease. Neurology 45: 1023.

Dallocchio, C., Buffa, C., Tinelli, C., and Mazzarello, P. (1999). Effectiveness of risperidone in Huntington Chorea patients. J. Clin. Psychopharmacol. 19: 101–103.

DeDeyn, P. P., Rabheru, K., Rasmussen, A., Bocksberger, J. P., Dautzenberg, P. L. J., Eriksson, S., and Lawlor, B. A. (1999). A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53: 946–955.

Devanand, D. P., and Levy, S. R. (1995). Neuroleptic treatment of agitation and psychosis in dementia. J. Geriatr. Psychiatry Neurol. 8(Suppl. 1): 518–527.

Doraiswamy, M., Martin, W., Metz, A., and Deveaughgeiss, J. (1995). Psychosis in Parkinsons-Disease—Diagnosis and treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 19: 835–846.

Durif, F., Vidailhet, M., Bonnet, A. M., and Agid, Y. (1996). Levodopa-induced dyskinesias are improved by low-dose clozapine. Neurology 46(suppl.): A476.

Eastham, J. H., and Jeste, D. V. (1997). Treatment of schizophrenia and delusional disorder in the elderly. Eur. Arch. Psychiatry Clin. Neurosc. 247: 209–218.

Evatt, M. L., Jewart, D., and Juncos, J. L. (1996). “Seroquel” (ICI 204,636) treatment of psychosis in parkinsonism. Mov. Disord. 11: 595.

Evidente, V. G. H., Gwinn-Hardy, K., Caviness, J. N., and Adler, C. H. (1999). Risperidone is effective in severe hemichorea/hemiballismus. Mov. Disord. 14: 377–379.

Factor, S. A., and Brown, D. (1992). Clozapine prevents recurrence of psychosis in Parkinsons-Disease. Mov. Disord. 7: 125–131.

Factor, S. A., Brown, D., Molho, E. S., and Podskalny, G. D. (1994). Clozapine—a 2-year open trial in Parkinson'sdisease patients with psychosis. Neurology 44: 544–546.

Factor, S. A., and Friedman, J. H. (1997). The emerging role of clozapine in the treatment of movement disorders. Mov. Disord. 12: 483–496.

Factor, S. A., Molho, E. S., and Brown, D. L. (1995). Combined clozapine and electroconvulsive-therapy for the treatment of drug-induced psychosis in Parkinsons-Disease. J. Neuropsychiatry Clin. Neurosc. 7: 304–307.

Fernandez, H. H., Friedman, J. H., Jacques, C., and Rosenfeld, M. (1999). Quetiapine for the treatment of druginduced psychosis in Parkinson's disease. Mov. Disord. 14: 484–487.

Fischer, P. A., Baas, H., and Hefner, R. (1990). Treatment of parkinsonian tremor with clozapine. J. Neural Transm. 2: 230–238.

Ford, B., Lynch, T., and Greene, P. (1994). Risperidone in Parkinson's disease. Lancet 344: 681.

Frankenburg, F. R., and Kalunian, D. (1994). Clozapine in the elderly. J. Geriatr. Psychiatry Neurol. 7: 129–132.

Friedman, J. H. (1998). Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology 50: 1195–1196.

Friedman, J. H. (The Parkinson Study Group). (1999). Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. The New Engl. J. Med. 340: 757–763.

Friedman, J. H., Goldstein, S., and Jacques, C. (1998). Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: Results of an open-label pilot study. Clin. Neuropharmacol. 21: 285–288.

Friedman, J. H., and Lannon, M. C. (1989). Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 39: 1219–1221.

Friedman, J. H., and Lannon, M. C. (1990). Clozapine-responsive tremor in Parkinsons-Disease. Mov. Disord. 5: 225–229.

Geroldi, G., Frisoni, B., Bianchetti, A., and Trabucchi, M. (1997). Drug treatment in Lewy body dementia. Dement. Geriatr. Cogn. Disord. 8: 188–197.

Goldberg, R. J., and Goldberg, J. (1996). Antipsychotics for dementia-related behavioral disturbances in elderly institutionalized patients. Clin. Geriatr. 4: 58–68.

Goldberg, R. J., and Goldberg, J. (1997). Risperidone for dementia-related disturbed behavior in nursing home residents: A clinical experience. Int. Psychogeriatr. 9: 65–68.

Graham, J. M., Sussman, J. D., Ford, K. S., and Sagar, H. J. (1998). Olanzapine in the treatment of hallucinosis in idiopathic parkinson's disease: A cautionary note. J. Neurol. Neurosurg. Psychiatry 65: 774–777.

Greene, P., Coté, L., and Fahn, S. (1993). Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Adv. Neurol. 60: 703–706.

Gregory, C., and McKenna, P. (1994). Pharmacological management of schizophrenia in older patients. Drugs Aging 5: 254–262.

Grossberg, G., and Manepalli, J. (1995). The older patient with psychotic symptoms. Psychiatr. Serv. 46: 55–60.

Hahn, R. K., Albers, L. J., and Reist, C. (1999- 2000). Current Clinical Strategies: Psychiatry, Current Clinical Strategies Publishing, Laguna Hills, CA.

Harris, M. J., and Jeste, D. V. (1988). Late-onset schizophrenia: An overview. Schizophr. Bull. 14: 39–55.

Helms, P. M. (1985). Efficacy of antipsychotics in the treatment of behavioral complications of dementia. J. Am. Geriatr. Soc. 33: 206–209.

Herrmann, N., Lanctô t, K. L., and Naranjo, C. A. (1996). Behavioural disorders in demented elderly patients— Current issues in pharmacotherapy. CNS Drugs 6: 280–300.

Herrmann, N., Rivard, M. F., Flynn, M., Ward, C., Rabheru, K., and Campbell, B. (1998). Risperidone for the treatment of behavioral disturbances in dementia: A case series. J. Neuropsychiatry Clin. Neurosc. 10: 220–223.

Hong, W. W., Aravanitis, L. A., Thyrum, P. T., and Wong, Y. W. J. (1996). The safety of “Seroquel” (ICI 204,623) in the treatment of elderly subjects with psychotic disorders. Eur. Neuropsychopharmacol. 6(suppl. 4): 126.

Honigfeld, G. (2000). Clozapine versus chlorpromazine in geriatric patients. J. Clin. Psychiatry 61: 63–64.

Howanitz, E., Pardo, M., Smelson, D. A., Engelhart, C., Eisenstein, N., and Losonczy, M. F. (1999). The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J. Clin. Psychiatry 60: 41–44.

Howard, R., Rabins, P. V., Seeman, M. V., Jeste, D. V., and The International Late-Onset Schizophrenia Group. (2000). Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. Am. J. Psychiatry 157: 172–178.

Irizarry, M. C., Binetti, T., Gomez-Isla, T., Hyman, B. T., and Growdon, J. H. (1996). Treatment of behavioral disturbances in dementia with risperidone. Neurology 46: 218.

Jansen, E. N. H. (1994). Clozapine in the treatment of tremor in Parkinson's-disease. Acta Neurol. Scand. 89: 262–265.

Jeanblanc, W., and Davis, Y. B. (1995). Risperidone for treating dementia-associated aggression [Letter]. Am. J. Psychiatry 152: 1239.

Jellinger, K. A., and Gabriel, E. (1999). No increased incidence of Alzheimer's disease in elderly schizophrenics. Acta Neuropathol. 97: 165–169.

Jeste, D. V. (1997). Psychiatry of old age is coming of age [editorial]. Am. J. Psychiatry 154: 1356–1358.

Jeste, D. V., Caliguiri, M. P., Paulsen, J. S., Heaton, R. K., Lacro, J. P., Harris, M. J., Bailey, A., Fell, R. L., and McAdams, L. A. (1995). Risk of tardive dyskinesia in older patients. Arch. Gen. Psychiatry 52: 756–765.

Jeste, D. V., Eastham, J. H., Lacro, J. P., Gierz, M., Field, M. G., and Harris, M. J. (1996). Management of late-life psychosis. J. Clin. Psychiatry 57: 39–45.

Jeste, D. V., Lacro, J. P., Bailey, A., Rockwell, E., Harris, M. J., and Caliguiri, M. P. (1999). Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J. Am. Geriatr. Soc. 47: 716–719.

Jeste, D. V., Lacro, J. P., Gilbert, P. L., Kline, J., and Kline, N. (1993). Treatment of late-life schizophrenia with neuroleptics. Schizophr. Bull. 19: 817–830.

Jeste, D. V., Rockwell, E., Harris, M. J., Lohr, J. B., and Lacro, J. (1999). Conventional vs. newer antipsychotics in elderly patients. Am. J. Geriatr. Psychiatry 7: 70–76.

Jiménez-Jiménez, F. J., Talló n-Barrano, A., Orti-Pareja, M., Zurdo, M., Porta, J., and Molina, J. A. (1998). Olanzapine can worsen parkinsonism. Neurology 50: 1183–1184.

Jones, K. M., and Stoukides, C. A. (1992). Clozapine in treatment of Parkinsons-Disease. Ann. Pharmacother. 26: 1386–1387.

Juncos, J. L. (1999). Management of psychotic aspects of Parkinson's disease. J. Clin. Psychiatry 60(suppl. 8): 42–53.

Juncos, J. L., Evatt, M. L., and Jewart, D. (1998). Long-term effects of quetiapine fumarate in parkinsonism complicated by psychosis. Neurology 50: 70–71.

Kahn, N., Freeman, A. M., Juncos, J. L., Manning D., and Watts, R. L. (1991). Clozapine is beneficial for psychosis in Parkinsons-Disease. Neurology 41: 1699–1700.

Kane, J., Honigfeld, G., Singer, J., Meltzer, H., and the Clozaril Collaboration Study Group. (1988). Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45: 789–796.

Katz, I. R., Jeste, D. V., Mintzer, J. E., Clyde, C., Napolitano, J., and Brecher, M. for the Risperidone study group. (1999). Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. J. Clin. Psychiatry 60: 107–115.

Kompoliti, K., and Goetz, C. (1998). Neuropharmacology in the elderly. Neurol. Clin. N. Am. 16: 599–611.

Kopala, L. C., and Honer, W. G. (1997). The use of risperidone in severely demented patients with persistent vocalizations. Int. J. Geriatr. Psychiatry 12: 73–77.

Kumar, V. (1997). Use of atypical antipsychotic agents in geriatric patients: A review. Int. J. Geriatr. Psychopharmacol. 1: 15–23.

Lacro, J. P., Eastham, J. H., Gilbert, P., Gierz, M., Aravagiri, M., and Jeste, D. V. (1996). Risperidone treatment in older patients with psychosis. Psychopharmacol. Bull. 32: 471.

Lake, J. T., Rahman, A. H., and Grossberg, G. T. (1997). Diagnosis and treatment of psychotic symptoms in elderly patients. Drugs Aging 11: 170–177.

Lanctô t, K. L., Best, T. S., Mittmann, N., Lui, B. A., Oh, P. I., Einarson, T. R., and Naranjo, C. A. (1998). Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. J. Clin. Psychiatry 59: 550–561.

Lavretsky, H., and Sulzer, D. (1998). A structured trial of risperidone for the treatment of agitation in dementia. Am. J. Geriatr. Psychiatry 6: 127–135.

Lew, M. F., and Waters, C. (1993). Clozapine treatment of parkinsonism with psychosis. J. Am. Geriatr. Soc. 41: 669–671.

Lieberman, J. A., and Tasman, A. (2000). Psychiatr. Drugs, Saunders, Philadelphia.

Linazasoro, G., Masso, J. F. M., and Suarez, J. A. (1993). Nocturnal akathisia in Parkinsons-Disease-treatment with clozapine. Mov. Disord. 8: 171–174.

Madhusoodanan, S., Brenner, R., and Alcantra, A. (2000). Clinical experience with quetiapine in elderly patients with psychotic disorders. J. Geriatr. Psychiatry Neurol. 13: 28–32.

Madhusoodanan, S., Brenner, R., Araujo, L., and Abaza, A. (1995). Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: A case series. J. Clin. Psychiatry 56: 514–518.

Madhusoodanan, S., Brenner, R., and Cohen, C. I. (1999). Role of atypical antipsychotics in the treatment of psychosis and agitation associated with dementia. CNS Drugs 12: 135–150.

Madhusoodanan, S., Suresh, P., Brenner, R., and Pillai, R. (1999). Experience with the atypical antipsychoticsrisperidone and olanzapine in the elderly. Ann. Clin. Psychiatry 11: 113–118.

Maixner, S. M., Mellow, A. M., and Tandon, R. (1999). The efficacy, safety and tolerability of antipsychotics in the elderly. J. Clin. Psychiatry 60(suppl. 8): 29–41.

McCarthy, R. H. (1994). Clozapine reduces essential tremor independent of its antipsychotic effect—a case-report. J. Clin. Psychopharmacol. 14: 212–213.

McManus, D. Q., Arvanitis, L. A., Kowalcyk, B. B., and Seroquel Trial 48 Study Group (1999). Seroquel (quetiapine), a novel antipsychotic: Experience in elderly patients with psychotic disorders. J. Clin. Psychiatry 60: 292–298.

Meco, G., Alessandria, A., Bonifati, V., and Giustini, P. (1994). Risperidone for hallucinations in L-dopa-treated Parkinson's disease patients. Lancet 343: 1370–1371.

Meltzer, H. Y., Kennedy, J., Dai, J., Parsa, M., and Riley, D. (1995). Plasma clozapine levels and the treatment of L-dopa-induced psychosis in Parkinsons-Disease-a high potency effect of clozapine. Neuropsychopharmacology 12: 39–45.

Molho, E. S., and Factor, S.A. (1999).Worsening of motor features of Parkinsonism with olanzapine. Mov. Disord. 14: 1014–1016.

Mulsant, B. H., and Gershon, S. (1993). Neuroleptics in the treatment of psychosis in late-life:Arational approach. Int. J. Geriatr. Psychiatry 8: 979–992.

Musser, W. S., and Akil, M. (1996). Clozapine as a treatment for psychosis in Parkinson's disease: A review. J. Neuropsychiatry Clin. Neurosc. 8: 1–9.

Naranjo, C. A., Herrmann, N., Mittmann, N., and Bremner, K. E. (1995). Recent advances in geriatric psychopharmacology. Drugs Aging 7: 184–202.

Oberholzer, A. F., Hendriksen, C., Monsch, A. U., Heierli, B., and Stähelin, H. B. (1992). Safety and effectiveness of low-dose clozapine in psychogeriatric patients: A preliminary study. Int. Psychogeriatr. 4: 187–195.

Ostergaard, K., and Dupont, E. (1988). Clozapine treatment of drug induced psychotic symptoms in later stages of Parkinson's disease. Acta Neurol. Scand. 78: 349–350.

Pakkenberg, H., and Pakkenberg, B. (1986). Clozapine in the treatment of tremor. Acta Neurol. Scand. 73: 295–297.

Parsa, M. A., and Bastani, B. (1998). Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease. J. Neuropsychiatry Clin. Neurosc. 10: 216–219.

Parsa, M. A., Simon, M., Dubrow, C., Ramirez, L. F., and Meltzer, H. Y. (1993). Psychiatric manifestations of olivo-ponto-cerebellar atrophy and treatment with clozapine. Int. J. Psychiatry Med. 23: 149–156.

Parsa, M. A., Szigethy, E., Voci, J. M., and Meltzer, H. Y. (1997). Risperidone in treatment of choreoathetosis of Huntington's disease. J. Clin. Psychopharmacol. 17: 134–135.

Pearlson, G. D., Kreger, L., Rabins, P. V., Chase, G. A., Cohen, B. M., Wirth, J. B., Schlaepfer, T. B., and Tune, L. E. (1989). A chart review study of late-onset and early-onset schizophrenia. Am. J. Psychiatry 146: 1568–1574.

Pfeiffer, R. F., Kang, J., Graber, B., Hofman, R., and Wilson, J. (1990). Clozapine for psychosis in Parkinsons-Disease. Mov. Disord. 5: 239–242.

Pfeiffer, C., and Wagner, M. L. (1994). Clozapine therapy for Parkinsons-Disease and other movement-disorders. Am. J. Hosp. Pharm. 51: 3047–3053.

Pickar, D. (1995). Prospects for pharmacotherapy of schizophrenia. Lancet 345: 557–562.

Pinter, M. M., and Helscher, R. J. (1993). Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinsons-Disease. J. Neural Transm. Park. Dis. Dement. Sect. 5: 135–146.

Pitner, J. K., Mintzer, J. E., Pennypacker, L. C., and Jackson, C.W. (1995). Efficacy and adverse-effects of clozapine in 4 elderly psychotic-patients. J. Clin. Psychiatry 56: 180–185.

Pollock, B., and Mulsant, B. H. (1995). Antipsychotics in older patients: A safety perspective. Drugs Aging 6: 3312–3323.

Rabey, J. M., Treves, T. A., Neufeld, M. Y., Orlov, E., and Korczyn, A. D. (1995). Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinsons-Disease. Neurology 45: 432–434.

Raheja, R. K., Bharwani, I, and Penetrante, A. E. (1995). Efficacy of risperidone for behavioral disorders in the elderly: A clinical observation. J. Geriatr. Psychiatry Neurol. 8: 159–161.

Raskin, D. E. (1985). Antipsychotic medication in the elderly. J. Clin. Psychiatry 46: 36–40.

Raskind, M. A., Risse, S. C., and Lampe, T. H. (1987). Dementia and antipsychotic drugs. J. Clin. Psychiatry 48(suppl.): 16–18.

Reveley, M. A., Dursun, S. M., and Andrews, H. A. (1996). A comparative trial use of sulpiride and risperidone in Huntington's disease: A pilot study. J. Psychopharmacol. 10: 162–165.

Rich, S. S., Friedman, J. H., and Ott, B. R. (1995). Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic syndromes. J. Clin. Psychiatry 56: 556–559.

Richelson, E. (1999). Receptor pharmacology of neuroleptics: Relation to clinical effects. J. Clin. Psychiatry 60 (suppl. 10): 5–14.

Roberts, H. E., Dean, R. C., and Stoudemire, A. (1989). Clozapine treatment of psychosis in Parkinson's disease. J. Neuropsychiatry Clin. Neurosc. 1: 190–192.

Rosenthal, S. H., Fenton, M. L., and Harnett, D. S. (1992). Clozapine for the treatment of levodopa-induced psychosis in Parkinsons-Disease. Gen. Hosp. Psychiatry 14: 285–286.

Rudolf, J., Ghaemi, M., and Schmulling, S. (1999). Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. Eur. Psychiatry 14: 356–357.

Safferman, A. Z., Kane, J. M., Aronowitz, J. S., Gordon, M. F., Pollock, S., and Lieberman, J. A. (1994). The use of clozapine in neurologic disorders. J. Clin. Psychiatry 55: 98–101.

Sajatovic, M., and Ramirez, L. (1995). Clozapine therapy in patients with neurologic illness. Int. J. Psychiatry Med. 25: 331–344.

Sajatovic, M., Ramirez, L. F., Vernon, L., Brescan, D., Simon, M., and Jurjus, G. (1996). Outcome of risperidone therapy in elderly patients with chronic psychosis. Int. J. Psychiatry Med. 26: 309–317.

Saltz, B. L., Woerner, M. G., Kane, J. M., Lieberman, J. A., Alvir, J.M. J., Bergmann, K. J., Blank, K., Koblenzer, J., and Kahaner, K. (1991). Prospective study of tardive dyskinesia incidence in the elderly. J. Am. Med. Assoc. 266: 2402–2406.

Salzman, C. (1987). Treatment of the elderly agitated patient. J. Clin. Psychiatry 48(suppl.): 19–22.

Salzman, C., Vaccaro, B., Lieff, J., and Weiner, A. (1995). Clozapine in older patients with psychosis and behavioral disruption. Am. J. Geriatr. Psychiatry 3: 26–33.

Schneider, L. S. (1999). Pharmacologic management of psychosis in dementia. J. Clini. Psychiatry 60(suppl. 8): 54–60.

Schneider, L. S., Pollock, V. E., and Lyness, S. A. (1990). A meta-analysis of controlled trials of neuroleptic treatment in dementia. J. Am. Geriatr. Soc. 38: 553–563.

Scholz, E., and Dichgans, J. (1985). Treatment of drug induced exogenous psychosis in parkinsonism with clozapine and fluperlapine. Eur. Arch. of Neurol. Sc. 235: 60–64.

Shulman, R.W., Singh, A., and Shulman, K. I. (1997). Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol. Bull. 33: 113–118.

Simoes, F., Garrett, C., Ramos, H., Curral, R., and Martine, R. (1992). Clozapine in the treatment of patients with tremor (parkinsonian, essential and neuroleptical-induced). Mov. Disord. 7(suppl. 1): 47.

Small, G. (1988). Psychopharmacological treatment of elderly demented patients. J. Clin. Psychiatry 49(suppl.): 8–13.

Stahl, S. M. (1999). Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. J. Clin. Psychiatry 60(suppl. 10): 31–41.

Stoppe, G., Brandt, C. A., and Staedt, J. H. (1999). Behavioral problems associated with dementia. The role of newer antipsychotics. Drugs Aging 14: 41–54.

Sweet, R. A., Mulsant, B. H., Gupta, B., Rifai, A. H., Pasternak, R. E., McEachran, A., and Zubenko, G. S. (1995a). Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life. Arch. Gen. Psychiatry 52: 478–486.

Sweet, R. A., and Pollock, B. G. (1998). New atypical antipsychotics—experience and utility in the elderly. Drugs Aging 12: 115–127.

Sweet, R. A., Pollock, B. G., Mulsant, B. H., Rosen, J., and Henteleff, R. A. (1995b). Prolactin response to neuroleptic challenge in late-life psychosis. Psychopharmacol. Bull. 31: 651–657.

Tandon, R., Milner, K., and Jibson, M. D. (1999). Antipsychotics from theory to practice: Integrating clinical and basic data. J. Clin. Psychiatry 60(suppl. 8): 21–28.

Targum, S. D., and Abbott, J. L. (1999). Psychosis in the elderly: A spectrum of disorders. J. Clin. Psychiatry 60(suppl. 8): 4–10.

Targum, S. D., and Abbott, J. L. (2000). Efficacy of quetiapine in Parkinson's patients with psychosis. J. Clin. Psychopharmacol. 20: 54–60.

Tariot, P., Gaile, S. E., Castelli, N. A., and Porsteinsson, A. P. (1997). Treatment of agitation in dementia. New Dir. Ment. Health Serv. 76: 109–123.

Toenniessan, L. M., Casey, D. E., and McFarland, B. H. (1984). Tardive dyskinesia in the aged. Arch. Gen. Psychiatry 42: 278–284.

Trosch, R. M., Friedman, J. H., Lannon, M. C., Pahwa, R., Smith, D., Seeberger, L. C., O'Brien, C. F., LeWitt, P. A., and Koller, W. C. (1998). Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience. Mov. Disord. 13: 377–382.

van Vugt, J. P. P., Siesling, S., Vergeer, M., van der Velde, E. A., and Roos, R. A. C. (1996). Clozapine versus placebo in Huntington's disease. Mov. Disord. 11(suppl. 1): 54.

Wagner, M. L., Defillippi, J. L., Menza, M. A., and Sage, J. I. (1996). Clozapine for the treatment of Parkinson's disease: Chart review of 49 patients. J. Neuropsychiatry Clin. Neurosc. 8: 276–280.

Weiner, W. J., Minagar, A., and Shulman, L. M. (1998). Olanzapine for the treatment of hallucinations/delusions in Parkinson's disease. Mov. Disord. 13(suppl. 2): 62.

Wirshing, W. C., Wirshing, D. A., Spellberg, B., and Amanios, T. (1998). A comparative review of atypical antipsychotics. Essential Psychopharmacol. 2: 431–461.

Woerner, M. G., Alvir, J. M. J., Kane, J. M., Saltz, B. L., and Lieberman, J. A. (1995). Neuroleptic treatment of elderly patients. Psychopharmacol. Bull. 31: 333–337.

Woerner, M. G., Alvir, J.M. J., Saltz, B. L., Lieberman, J. A., and Kane, J. M. (1998). Prospective study of tardive dyskinesia in the elderly: Rates and risk factors. Am. J. Psychiatry 155: 1521–1528.

Wolk, S. I., and Douglas, C. J. (1992). Clozapine treatment of psychosis in Parkinsons-Disease—a report of 5 consecutive cases. J. Clin. Psychiatry 53: 373–376.

Wolters, E. C., Hurwitz, I. A., Peppard, F. R., and Calne, D. B. (1989). Clozapine: An antipsychotic agent for Parkinson's disease? Clin. Neuropharmacol. 12: 83–90.

Wolters, E. C., Hurwitz, R. E., Mak, E., Teal, P., Peppard, F. R., Remick, R., Calne, S., and Calne, D. B. (1990). Clozapine in the treatment of parkinsonian patients with dopaminergic psychosis. Neurology 40: 832–834.

Wolters, E. C., Jansen, E. N. H., Tuyman-Qua, H. G., and Bergmans, P. L. M. (1996). Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology 47: 1085–1087.

Workman, R. H. Jr., Orengo, C. A., Bakey, A. A., Molinari, V. A., and Kunik, M. E. (1997). The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. J. Neuropsychiatry Clin. Neurosc. 9: 594–597.

Yassa, R., Nair, V., and Schwartz, G. (1986). Early versus late onset psychosis and tardive dyskinesia. Biol. Psychiatry 21: 1291–1297.

Yassa, R., Nastase, C., Dupont, D., and Thibeau, M. (1992). Tardive dyskinesia in elderly psychatric patients: A 5-year study. Am. J. Psychiatry 149: 1206–1211.

Young, C. R., Longhurst, J. G., Bowers, M. B. Jr., and Mazure, C. M. (1997). The expanding indications for clozapine. Exp. Clin. Psychopharmacol. 5: 216–234.

Zarate, C. A. Jr., Baldessarini, R. J., Siegel, A. J., Nakamura, A., McDonald, J., Muir-Hutchinson, L. A., Cherkerzian, T., and Tohen, M. (1997). Risperidone in the elderly: A pharmacoepidemiologic study. J. Clin. Psychiatry 58: 311–317.